Why is the Fed's $2.5B HQ renovation under scrutiny?
How are Trump's tariffs impacting Amazon prices?
Why did Ark Invest sell Coinbase shares recently?
What caused Alaska Airlines to ground all flights?
How will AstraZeneca’s $50B US investment affect pharma?
Why is Opendoor stock surging amid volatility?
How is AI reshaping small business back offices?
GSK's Blood Cancer Drug Faces US Setback Due To FDA Panel's Eye Safety Warning
benzinga.com/news/fda/25/07/46489262/gsks-blood-cancer-drug-faces-us-setback-due-to-fda-panels-eye-safety-warning
The U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) combinations.
The belantamab mafodotin combinations were evaluated in…
This story appeared on benzinga.com, 2025-07-18 11:32:19.